sepiapterin reductase inhibitors (Quartet Medicine/Merck)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namesepiapterin reductase inhibitors (Quartet Medicine/Merck)
Drug Alias Namesepiapterin reductase inhibitors (Quartet Medicine)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSepiapterin reductase inhibitors
TargetsSepiapterin reductase
Therapy Area/IndicationsPainInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesQuartet Medicine
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesQuartet MedicineMerck & Co Inc
Active IndicationsN/A
Inactive IndicationsPainInflammation

Other Information

ATC CodeN/A
Related LinksN/A